{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/nappy-rash/management/management/","result":{"pageContext":{"chapter":{"id":"e22f1fdc-9a01-51a6-9519-694c4dc68f3e","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 8a58710d-e36f-4fe2-8af0-34a1e1f9db6d --><h2>Scenario: Management of nappy rash</h2><!-- end field 8a58710d-e36f-4fe2-8af0-34a1e1f9db6d -->","summary":"Covers the management of children with nappy rash in primary care.","htmlStringContent":"<!-- begin item 3a1d4814-d165-4dcd-b9a1-2af129a24ba3 --><!-- begin field c6f03af2-71bb-4bd6-8e61-acbc01594963 --><p>From birth to 6 years.</p><!-- end field c6f03af2-71bb-4bd6-8e61-acbc01594963 --><!-- end item 3a1d4814-d165-4dcd-b9a1-2af129a24ba3 -->","topic":{"id":"fced145b-8234-5cd6-8495-21dd435fa09e","topicId":"bf5cc007-7a69-42da-9cce-026e01ec0830","topicName":"Nappy rash","slug":"nappy-rash","lastRevised":"Last revised in September 2020","chapters":[{"id":"6bd868d7-97dc-5abb-9dd7-5bd8d9a45b42","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"285ad030-4a43-587e-b95d-111b05082bd7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"51cba348-0401-515c-b0cb-403accf300bb","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3faf55b7-5b1b-55f9-87fa-6c77ae443435","slug":"changes","fullItemName":"Changes"},{"id":"5d2e0f7f-32f0-515c-acf8-f41a7793f377","slug":"update","fullItemName":"Update"}]},{"id":"6afe2031-7d04-5d34-8f93-9f76b0cee31f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"df2b7ca6-faa1-5155-b6f8-e38e875710a9","slug":"goals","fullItemName":"Goals"},{"id":"c88d8b1e-a003-5fdb-8125-60256108c8fd","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2381dd75-9264-51ce-923a-ffd47d06fb70","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9148277c-7b69-5abd-96e6-6da6cdc0692c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e337d403-433f-5884-ad90-0dc4725b9e10","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"98137183-55d3-54da-8a82-f70edd211099","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2308d842-41bc-5c6e-b14f-7a732380baae","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"25c232ac-1d36-5623-a083-670842228d71","slug":"definition","fullItemName":"Definition"},{"id":"d6bc684b-0cf9-51f4-880a-68386599241c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0baab6c3-f7e8-573b-96ee-4e51d9cb5330","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e6a2c35-a2df-5ed9-8430-1d28fa50879e","slug":"complications","fullItemName":"Complications"},{"id":"808d9af1-4926-59a3-80ef-e810780e9314","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"34a7e7aa-63d3-5df0-9b78-2d694441515e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0f83f809-aed6-51e2-990d-c63ccf224d4e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"36a8ef6d-dd7b-5e24-88b6-2e0d2e428522","slug":"assessment","fullItemName":"Assessment"},{"id":"da38cadb-36b7-5e94-a4d2-1ac880a9fc14","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"512f5f04-323c-5417-9d49-118aaf08ef60","fullItemName":"Management","slug":"management","subChapters":[{"id":"e22f1fdc-9a01-51a6-9519-694c4dc68f3e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"919d8121-c385-56c1-a44a-d1b60e0744d8","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"54149fa7-c48e-56d7-909c-d76fceaaa0b6","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"3e0033c5-591d-5608-8277-0cb6706398f5","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"4a82e127-a2d6-5fae-9103-e83494a28d24","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"01431b56-1a68-53cb-9666-0bc883bec5ff","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"186815e3-961f-5ab5-b89d-b7d341d8851a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c9ab642f-9b46-54ff-a595-1e9168cbfdff","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a12c552f-6d1a-5409-a5cf-dc1efba7bb2a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d9167d23-de60-534b-b0da-c093d3a37b23","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"33ede077-9ff7-58b7-981d-d4dd371561b0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"db7928f1-0104-5ed1-8880-c59b9f060e6f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96311897-ae0a-5de9-a6a0-0cb5e181a4d3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"512f5f04-323c-5417-9d49-118aaf08ef60","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"52ed6d69-3962-5126-abd2-ce1009ffecb2","slug":"initial-management","fullItemName":"Initial management","depth":3,"htmlHeader":"<!-- begin field c73eb5bf-9c95-4ba5-9429-a6b300cb5108 --><h3>How should I initially manage nappy rash?</h3><!-- end field c73eb5bf-9c95-4ba5-9429-a6b300cb5108 -->","summary":null,"htmlStringContent":"<!-- begin item de249437-f854-4ef5-9690-a6b300cb4f14 --><!-- begin field b1a1295e-8998-4f15-bbba-a6b300cb5108 --><ul><li><strong>Advise the parents/carers on self-management strategies.</strong><ul><li>Consider using a nappy with high absorbency (for example, disposable gel matrix nappies compared with non-disposable nappies).<ul><li>Ensure the nappy fits properly (too tight increases skin occlusion; too loose minimizes absorption of fluids).</li><li>Parental/carer choice will depend on issues such as convenience, cost, and environmental impact.</li></ul></li><li>Leave nappies off for as long as possible to help skin drying of the nappy area.</li><li>Clean the skin and change the nappy every 3–4 hours, or as soon as possible after wetting or soiling, to reduce skin exposure to urine and faeces.<ul><li>Use water, or fragrance-free and alcohol-free baby wipes.</li><li>Dry gently after cleaning — avoid vigorous rubbing.</li><li>Bath the child daily — avoid excessive bathing (such as more than twice a day) which may dry the skin excessively.</li><li>Do not use soap, bubble bath, lotions, talcum powder, or topical antibiotics which can have an irritant effect.</li></ul></li></ul></li><li><strong>Advise on sources of written information and support,</strong> such as:<ul><li>The NHS A-Z information leaflet on <a href=\"https://www.nhs.uk/conditions/pregnancy-and-baby/nappy-rash/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"cf089fef-b562-49bb-9af3-a90500cf7ab7\">Nappy rash</a>.</li><li>The information leaflet on <a href=\"https://patient.info/health/nappy-rash-leaflet\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"c18e9d27-9135-45fd-923d-a90500cf7aba\">Nappy rash</a> available on the <a href=\"https://patient.info/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"46e47aed-8d86-4b5b-b922-a91200a03a3b\">www.patient.info</a> website.</li></ul></li><li><strong>If there is mild erythema and the child is asymptomatic:</strong><ul><li>Advise on the use of a barrier preparation to protect the skin, which are available to buy over-the-counter.</li><li>Advise to apply thinly at each nappy change.<ul><li>A range of options are available, including Zinc and Castor Oil ointment and white soft paraffin BP ointment.</li></ul></li></ul></li><li><strong>If the rash appears inflamed and is causing discomfort:</strong><ul><li>For children over 1 month of age, consider prescribing topical hydrocortisone 1% cream once a day in addition, until symptoms settle or for a maximum of seven days.<ul><li>Advise parents to apply topical hydrocortisone first and wait a few minutes before applying the barrier preparation.</li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more prescribing information.</li></ul></li></ul></li><li><strong>If the rash persists and <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/diagnosis/assessment/\">Candidal infection</a> is suspected or confirmed on swab:</strong><ul><li>Advise against the use of a barrier preparation until the candidal infection has settled.</li><li>Prescribe a topical imidazole cream, the frequency depending on the preparation used.<ul><li>Options include topical clotrimazole, econazole, or miconazole.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/prescribing-information/topical-imidazoles/\">Topical imidazoles</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/prescribing-information/\">Prescribing information</a> for information on the frequency of application and duration of treatment.</li></ul></li></ul></li><li><strong>If the rash persists and <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/diagnosis/assessment/\">bacterial infection</a> is suspected or confirmed on swab:</strong><ul><li>Prescribe oral flucloxacillin for seven days. If the child is allergic to penicillin, prescribe oral clarithromycin for seven days.<ul><li>Adjust the choice of antibiotic if indicated, depending on swab results.</li><li>See the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/prescribing-information/flucloxacillin/\">Flucloxacillin</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/prescribing-information/clarithromycin/\">Clarithromycin</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/prescribing-information/\">Prescribing information</a> for more information including dosage regimens.</li></ul></li></ul></li><li><strong>Arrange to review the child,</strong> the time interval depending on clinical judgement, to assess the response to treatment.<ul><li>If symptoms are not settling, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/management/management/#treatment-failure-referral\">Treatment failure and referral</a> for more information.</li></ul></li></ul><!-- end field b1a1295e-8998-4f15-bbba-a6b300cb5108 --><!-- end item de249437-f854-4ef5-9690-a6b300cb4f14 -->","subChapters":[{"id":"17586820-c297-5b2d-a7e3-b2fe524be874","slug":"basis-for-recommendation-953","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 0f9879e3-5390-4d9f-8c14-a6b300cb5108 --><h4>Basis for recommendation</h4><!-- end field 0f9879e3-5390-4d9f-8c14-a6b300cb5108 -->","summary":null,"htmlStringContent":"<!-- begin item 953495c5-23d2-40be-8d30-a6b300cb5108 --><!-- begin field c9cba5b6-c8cf-465d-ac42-a6b300cb5108 --><p>The recommendations on management are largely based on a Cochrane systematic review <em>Disposable nappies for preventing napkin dermatitis in infants</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Baer et al, 2006</a>], and expert opinion in review articles on nappy rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Lund, 1999</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Visscher, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Stamatas, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Atherton, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Cohen, 2017</a>].</p><h5>Offering advice on self-management strategies</h5><ul><li>The recommendations on self-management advice are largely based on expert opinion in multiple review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Visscher, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Stamatas, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Atherton, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Cohen, 2017</a>].<ul><li>A Cochrane systematic review evaluated 17 randomized controlled trials (RCTs) and found insufficient evidence from good-quality RCTs to support or refute the use and type of disposable nappies for the prevention of nappy rash in infants. It suggested the available studies favour breathable, gel matrix nappies, however, the results should be viewed with caution as all the studies were subject to significant bias [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Baer et al, 2006</a>].</li><li>More recently, expert opinion in review articles state that nappies with absorbent gel material wick moisture away from the skin surface efficiently [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Visscher, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>]. In addition, disposable nappies aim to prevent over-hydration of the skin and maintain appropriate skin pH levels [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>]. Improved nappy design has resulted in an outer breathable backsheet which reduces the occlusive effect of the nappy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Atherton, 2016</a>].</li><li>Baby wipes which have an acidic pH may buffer alkaline urine and restore normal skin pH, which reduces the irritant effect of urine on the skin [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Atherton, 2016</a>]. Studies have shown that using alcohol- and fragrance-free baby wipes in healthy infants results in less erythema and surface roughness compared with using water alone with a cotton washcloth or cotton wool balls [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Visscher, 2009</a>].</li><li>Exposing the nappy area skin to air reduces the time in contact with urine, faeces, moisture, and other irritants. It also decreases frictional damage of the skin in contact with the nappy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>].</li><li>The recommendation to avoid soap and detergents is based on the fact that they may raise skin pH in infants which can compromise the barrier function of the epidermis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>].</li><li>The recommendation to avoid topical preparations such as talculm powder and antibiotics is based on the fact that they may cause irritant contact dermatitis and worsen the rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>]. Expert opinion in a review article also notes that topical antibiotics are generally not recommended [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>].</li></ul></li></ul><h5>Offering advice on barrier preparations</h5><ul><li>The recommendation to use barrier preparations is based on the fact that they provide a protective lipid film that reduces skin contact with faeces and urine, reduces humidity, and minimizes transepidermal water loss, which reduces potential skin irritation and maceration [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Stamatas, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Atherton, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Cohen, 2017</a>].<ul><li>Expert opinion in a review article notes that there is a lack of evidence on the effectiveness of different barrier preparations compared with each other [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>].</li><li>Expert opinion in a review article on neonatal skin care notes that preservative-free zinc oxide ointment and petroleum-based ointments are safe and inexpensive options. Ointments are generally more effective than creams and lotions, as they provide a better moisture barrier [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>].</li><li>The recommendation to apply the barrier preparation as a thin layer is based on the fact that applying a moisture barrier layer too thickly may cause water retention and worsen any skin maceration. This is supported by the expert opinion of previous external reviewers of this CKS topic.</li></ul></li></ul><h5>Managing associated inflammation</h5><ul><li>The recommendation to consider the use of topical hydrocortisone for skin inflammation is extrapolated from expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>] and the British National Formulary (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">BNF for Children, 2017</a>].<ul><li>The recommendation to use up to seven days duration of topical corticosteroid is based on expert opinion in the BNF and in a review article, as the occlusive effect of nappies may increase the risk of skin penetration and potency of corticosteroids, and increase the risk of adverse effects such as skin atrophy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>]. It is also based on the expert opinion of previous external reviewers of this CKS topic.</li><li>The recommendation to apply any barrier preparation after the topical corticosteroid is based on expert opinion in the BNF.</li></ul></li></ul><h5>Managing candidal infection</h5><ul><li>The recommendation to prescribe a topical imidazole if there is suspected candida infection is largely based on expert opinion in multiple review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Visscher, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].<ul><li>Expert opinion in review articles recommends to consider candidal infection in any nappy rash that fails to respond to standard treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>] or that persists for more than three days [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].</li><li>CKS found no good-quality evidence for the comparative effectiveness of different topical imidazole preparations for the management of nappy rash.</li><li>The recommendation to stop using a barrier preparation when using a topical imidazole to treat candidal infection is based on limited evidence from a US review article on infant skin care, which suggests that the rash may worsen if a water-resistant barrier preparation is used before the underlying infection is treated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Lund, 1999</a>]. This is supported by the expert opinion of previous external reviewers of this CKS topic.</li></ul></li></ul><h5>Managing bacterial infection</h5><ul><li>The recommendation to prescribe an oral antibiotic if there is suspected bacterial infection is largely based on expert opinion in review articles, which state that S<em>taphylococcus aureus</em> and streptococcus are the most likely causes of bacterial infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Visscher, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].<ul><li>The recommendation on the use of flucloxacillin first-line for suspected or confirmed bacterial infection is extrapolated from expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>]. It is also pragmatic, based on what CKS considers to be good clinical practice, as this antibiotic has activity against group A beta-haemolytic streptococci and <em>Staphylococcus aureus</em>. This approach is supported by the expert opinion of previous external reviewers of this CKS topic.</li><li>Topical antibiotics are not generally recommended as they may cause irritant contact dermatitis and worsen the rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ness, 2013</a>].</li></ul></li></ul><!-- end field c9cba5b6-c8cf-465d-ac42-a6b300cb5108 --><!-- end item 953495c5-23d2-40be-8d30-a6b300cb5108 -->","subChapters":[]}]},{"id":"8188f44b-6a22-5f70-8d37-09b41c0a5c7a","slug":"treatment-failure-referral","fullItemName":"Treatment failure and referral","depth":3,"htmlHeader":"<!-- begin field 3d8dd22a-25b2-40aa-930f-a7460120783c --><h3>How should I manage treatment failure?</h3><!-- end field 3d8dd22a-25b2-40aa-930f-a7460120783c -->","summary":null,"htmlStringContent":"<!-- begin item d3426711-edc5-4f12-a282-a746012069a3 --><!-- begin field 28fa2c66-1231-49d3-8acf-a7460120783c --><p><strong>If suspected nappy rash is not improving following <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/management/management/#initial-management\">initial management</a>:</strong></p><ul><li>Consider and, if possible, manage any underlying cause of treatment failure. This may include:<ul><li>Non-adherence to <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/management/management/#initial-management\">self-care advice</a> or the treatment regimen.</li><li>Candidal or bacterial secondary infection — take a skin swab for culture and sensitivity, and manage accordingly. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/management/management/#initial-management\">Initial management</a> for more information.</li><li>An <a class=\"topic-reference internal-reference\" href=\"/topics/nappy-rash/diagnosis/differential-diagnosis/\">alternative cause</a> for the rash.</li><li>An immunocompromised host.</li></ul></li><li>If the rash persists following treatment for secondary infection:<ul><li>Adjust the choice of topical imidazole or oral antibiotic if indicated, depending on swab results <em>or</em></li><li>Seek specialist advice from a medical microbiologist, if the rash has not responded to appropriate treatment.</li></ul></li><li>Consider referral to a paediatric dermatologist if:<ul><li>There is uncertainty about the diagnosis.</li><li>The rash persists despite optimal treatment in primary care.</li><li>There are recurrent, severe unexplained episodes.</li></ul></li></ul><!-- end field 28fa2c66-1231-49d3-8acf-a7460120783c --><!-- end item d3426711-edc5-4f12-a282-a746012069a3 -->","subChapters":[{"id":"2dade227-d442-5132-a096-453dc8d76ab1","slug":"basis-for-recommendation-d9a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7f9a6c34-220e-4186-827e-a7460120787e --><h4>Basis for recommendation</h4><!-- end field 7f9a6c34-220e-4186-827e-a7460120787e -->","summary":null,"htmlStringContent":"<!-- begin item d9a134a7-c97d-4547-8c82-a7460120787e --><!-- begin field 6417baa2-0f73-4d5d-b462-a7460120787e --><p>The recommendations on treatment failure and when to refer are largely based on expert opinion in review articles on nappy rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].</p><ul><li>If nappy rash does not resolve with standard treatments, the child must be evaluated for underlying disease or an alternative condition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Merrill, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].</li><li>The recommendation to consider seeking advice from a medical microbiologist if nappy rash does not respond to appropriate imidazole or antibiotic treatment in primary care is pragmatic, based on what CKS considers to be good clinical practice.</li><li>Further investigations such as patch testing may be helpful if there is refractory nappy rash, to exclude conditions such as allergic contact dermatitis with sensitization to specific allergens [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Ravanfar et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].</li><li>Nappy rash with atypical features and negative swab results may require further specialist investigations, such as skin biopsy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].</li><li>Recurrent and refractory cases of nappy rash may require systemic antifungal therapy, and if the rash is severe or chronic with erosions or ulceration, this may be a sign of underlying immunocompromise which requires further investigation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Coughlin, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">Van Gysel, 2016</a>].</li></ul><!-- end field 6417baa2-0f73-4d5d-b462-a7460120787e --><!-- end item d9a134a7-c97d-4547-8c82-a7460120787e -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}